Literature DB >> 2636803

Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis.

A H Rook1, B Freundlich, G T Nahass, R Washko, B Macelis, M Skolnicki, P Bromley, W K Witmer, B V Jegasothy.   

Abstract

In this report, we describe the use of extracorporeal photochemotherapy in n the treatment of two patients with rapidly advancing progressive systemic sclerosis. Both patients experienced improvement in the cutaneous as well as the systemic manifestations of their disease while undergoing therapy. The potential therapeutic mechanisms are discussed.

Entities:  

Mesh：

Year:  1989        PMID： 2636803      PMCID： PMC2589144     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


  6 in total

1.  Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels.

Authors:  J Rosenbloom; G Feldman; B Freundlich; S A Jimenez
Journal:  Arthritis Rheum       Date:  1986-07

2.  Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations.

Authors:  A D Roumm; T L Whiteside; T A Medsger; G P Rodnan
Journal:  Arthritis Rheum       Date:  1984-06

3.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.

Authors:  R Edelson; C Berger; F Gasparro; B Jegasothy; P Heald; B Wintroub; E Vonderheid; R Knobler; K Wolff; G Plewig
Journal:  N Engl J Med       Date:  1987-02-05       Impact factor: 91.245

4.  Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy.

Authors:  B Freundlich; S A Jimenez
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

5.  Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.

Authors:  M Perez; R Edelson; L Laroche; C Berger
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

Review 6.  Regulation of autoimmune disease physiological and therapeutic.

Authors:  I R Cohen
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988
  6 in total
  3 in total

1.  Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations.

Authors:  R M Knobler
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.

Authors:  Paolo Perseghin
Journal:  Transfus Med Hemother       Date:  2007-12-21       Impact factor: 3.747

3.  Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.

Authors:  B Prinz; W Behrens; E Hölzle; G Plewig
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.